The PLATINUM Diversity Study presented at TCT 2016
This study evaluate the clinical outcomes of the Promus PREMIER™ Stent in women and minorities. The results showed that there were no significant outcome differences between white men and women or minorities for the composite primary endpoint of death, myocardial infarction or target vessel revascularization at 12 months. See Dr. C. M. Gibson and Dr. W. Batchelor’s discussion on the PLATINUM DIVERSITY Study.
The SYNERGY™ Stent: Zero is on Safety through Angioscopy
The SYENRGY™ Stent, with its abluminal, bioabsorbable polymer, is a new category of device that shows more complete stent coverage compared to permanent polymer stents. Through angioscopy, we have a unique view into vessel healing with various generations of drug-eluting stents.